Interview with André Choulika, President, France Biotech
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this?…
FAREVA is one of the world’s leading subcontractors in the Industrial & Household, Cosmetics and Pharmaceuticals fields.Our story began in 1990, in France, in the heart of Ardèche region, with a team of passionate enthusiasts that moved into the world of chemistry and developed its core business in research, formulation, manufacturing and packaging. From the very beginning, FAREVA always focused on creation, innovation and mastering processes to offer its customers cutting-edge expertise. Fareva is the leading CMO organization in France and worldwide with €1.3 billion in turnover in 2015, more than 10,000 international employees and 1,000 leading international customers worlwide.
Contact
Fareva Corporation France
Les Iles Feray
07300 Touron – France
+33 475 078 229
+33 01 64 87 30 00
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this?…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market. Can you explain…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the French model rewards innovative…
What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The main idea is that…
See our Cookie Privacy Policy Here
